Sec. 797. Kidney disease, research, surveillance, prevention, and treatment
345 words·~2 min read·
/bill/116/s/4819/is/section-797·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
This section may be cited as the Kidney Disease Research, Surveillance, Prevention and Treatment Improvement Act of 2020 . Congress makes the following findings: Kidney diseases impact 37,000,000 individuals in the United States. African Americans comprise just 13 percent of the United States population, but 33 percent of the United States dialysis patient population. Compared to Caucasians, kidney failure prevalence is about 3.7 times greater in African Americans, 1.4 times greater in Native Americans, and 1.5 times greater in Asian Americans.
Peritoneal dialysis and home hemodialysis use is 40–50 percent lower among African Americans and Hispanics. Every racial and ethnic minority group in the United States is significantly less likely to be treated with home dialysis than Whites, and demographic and clinical characteristics are insufficient to explain this differential use. African Americans on dialysis, irrespective of dialysis modality, and Hispanics undergoing PD or in-center HD, are significantly less likely than their White counterparts to receive a kidney transplant.
African Americans, Hispanics, and Asian Americans are less likely to receive living donor kidney transplants than Whites. Efforts to reduce disparities in live donor kidney transplantation for African-American, Hispanic, and Asian patients with kidney failure have been unsuccessful. Medicare and Medicaid patients are less likely to receive a preemptive transplant from a deceased donor compared to private insurance patients (5 percent and 11 percent versus 24 percent), and Black and Hispanic patients are less likely to receive a preemptive transplant from a deceased donor compared with White patients even after changes to the kidney allocation system (5 percent of Black patients and 5 percent of Hispanic patients compared with 18 percent of White patients).
Low-income populations are significantly more likely to progress to kidney failure. Low socioeconomic status is associated with increased incidence of chronic kidney disease, progression to kidney failure, inadequate dialysis treatment, and reduced access to kidney transplantation. The 3 goals of Executive Order 13879 of July 10, 2019 (84 Fed. Reg. 33817; relating to Advancing American Kidney Health), recognizes the need for more transplants, better prevention and education, and improved access to treatment modalities.
Connectionstraces to 1
Traces to 1 document
register
1 reference not yet in our index
- 84 FR 33817
Citation graph
cites case law
Sec. 797
Kidney disease, research, surveillance, prevention, and treatment
Fed. Reg.84 FR 33817
Cites 2Cited by 0 across 0 sources